Legend Biotech Corporation American Depositary Shares (LEGN)
- Headquarters
- United States
- Employees
- 2,900
- Market Cap
- $3.7B
About Legend Biotech Corporation American Depositary Shares
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
SentiSense also tracks daily options readings for Legend Biotech Corporation American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Legend Biotech Corporation American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.